Sales and Marketing

Showing 15 posts of 11524 posts found.

Novartis

Novartis’ brain tumour drug Votubia launched in UK

September 29, 2011 Sales and Marketing Afinitor, Votubia

Novartis has launched its orphan drug Votubia in the UK for patients with a rare type of brain tumour. Votubia …
Gardasil

Gardasil better value for money than Cervarix, finds new study

September 28, 2011 Sales and Marketing Cervarix, Gardasil, HPV, cervical cancer

A new report by the Health Protection Agency has found that Gardasil is a more cost-effective vaccine for cervical cancer …

Cancer costs on an ‘unaffordable trajectory’

September 28, 2011 Sales and Marketing Cancer, healthcare costs

The cost of cancer is rising too fast with new treatments giving uncertain benefits, according to a new study. A …

Bridgehead International appoints Marcus Deans

September 26, 2011 Sales and Marketing appointment, sales and marketing

London-based consultants Bridgehead International have appointed Marcus Deans as principal consultant. He joins the firm, which specialises in market access, …

Xarelto poised for two new chronic indications

September 26, 2011 Sales and Marketing Xarelto

Bayer HealthCare’s oral bloodthinner Xarelto has been recommended for approval in Europe for two new chronic indications. The Committee for …

Roche’s Avastin set for new ovarian cancer indication in Europe

September 26, 2011 Sales and Marketing avastin, ovarian cancer

Roche’s Avastin has gained the backing of European regulatory advisors for a new indication in ovarian cancer. The European Medicines …
Sanofi's Multaq

Safety concerns prompt Multaq restrictions

September 26, 2011 Sales and Marketing Multaq

The European Medicines Agency has recommended Sanofi’s Multaq be restricted due to ongoing concerns about its safety profile. The drug …
Roche's Avastin

Avastin faces greater scrutiny over eye disease use

September 23, 2011 Sales and Marketing avastin, macular oedema

The use of Roche’s Avastin to treat eye disease has come under greater scrutiny after a series of infections in …

Roche cleared over rep conduct complaint

September 23, 2011 Sales and Marketing ABPI Code of Practice, Roche

Roche has been cleared by Code regulator the PMCPA of any wrongdoing after an NHS employee complained about the promotion …

Value-based pricing won’t encourage innovation, says ABPI

September 23, 2011 Sales and Marketing value-based pricing

The ABPI has come out against the government’s reforms of drug pricing in the UK, saying its plans need a …

NHS ‘wasted’ £625 million on modern insulin

September 23, 2011 Sales and Marketing diabetes, insulin

The NHS has wasted £625 million on modern insulin products over the last decade, according to a new report in …

Healthcare 2025: what the future holds for pharma

September 22, 2011 Manufacturing and Production, Research and Development, Sales and Marketing NHS reform, healthcare reform, healthcare spending, prescribing

We are in the middle of a huge upheaval where everything we know is being turned on its head. Welcome …

J&J’s hep C drug Incivo approved in Europe

September 22, 2011 Sales and Marketing Incivek, Incivo, Victrelis

J&J’s potential blockbuster hepatitis C treatment Incivo has been approved in Europe. Incivo (telaprevir) was approved in combination with peginterferon …

Pfizer to cut 11% of its workforce in Spain

September 22, 2011 Sales and Marketing Pfizer, Spain, job cuts

Pfizer will cut 220 jobs in Spain as the government reduces spending on pharmaceuticals to help offset its growing debt …
President Obama

Obama proposes seven year rule for biologics

September 21, 2011 Research and Development, Sales and Marketing Obama, biologics

President Obama has returned to the issue of market exclusivity for biologic drugs as a way of cutting healthcare costs. …
The Gateway to Local Adoption Series

Latest content